Tumor-intrinsic NLRP3-HSP70-TLR4 axis drives premetastatic niche development and hyperprogression during anti-PD-1 immunotherapy.
Journal
Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086
Informations de publication
Date de publication:
23 11 2022
23 11 2022
Historique:
entrez:
23
11
2022
pubmed:
24
11
2022
medline:
26
11
2022
Statut:
ppublish
Résumé
The tumor-intrinsic NOD-, LRR- and pyrin domain-containing protein-3 (NLRP3) inflammasome-heat shock protein 70 (HSP70) signaling axis is triggered by CD8
Identifiants
pubmed: 36417489
doi: 10.1126/scitranslmed.abq7019
pmc: PMC10347419
mid: NIHMS1905126
doi:
Substances chimiques
Toll-Like Receptor 4
0
NLR Family, Pyrin Domain-Containing 3 Protein
0
HSP70 Heat-Shock Proteins
0
TLR4 protein, human
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
eabq7019Subventions
Organisme : NCI NIH HHS
ID : F32 CA247067
Pays : United States
Organisme : NCI NIH HHS
ID : R37 CA249085
Pays : United States
Références
Cancers (Basel). 2021 Jan 15;13(2):
pubmed: 33467713
BMC Cancer. 2018 May 2;18(1):500
pubmed: 29716544
Cancer Immunol Res. 2015 Sep;3(9):1082-95
pubmed: 26041736
Curr Protoc Immunol. 2001 May;Chapter 20:Unit 20.2
pubmed: 18432775
Cancers (Basel). 2021 Sep 23;13(19):
pubmed: 34638239
FASEB J. 2013 Apr;27(4):1631-43
pubmed: 23254341
Nat Commun. 2022 Mar 25;13(1):1606
pubmed: 35338135
Circ Res. 2001 Jul 6;89(1):20-5
pubmed: 11440973
Proc Natl Acad Sci U S A. 2021 Mar 9;118(10):
pubmed: 33649199
Proc Natl Acad Sci U S A. 2019 May 14;116(20):9999-10008
pubmed: 31028147
Immunity. 2018 Jan 16;48(1):147-160.e7
pubmed: 29343435
Nat Rev Cancer. 2017 May;17(5):302-317
pubmed: 28303905
J Clin Invest. 2020 May 1;130(5):2570-2586
pubmed: 32017708
Cell Rep. 2015 Nov 3;13(5):898-905
pubmed: 26565903
Anticancer Res. 2005 Nov-Dec;25(6B):3905-15
pubmed: 16312045
PLoS One. 2012;7(9):e46076
pubmed: 23049940
Nat Rev Clin Oncol. 2018 Dec;15(12):748-762
pubmed: 30361681
Sci Immunol. 2020 Jan 3;5(43):
pubmed: 31901074
J Biol Chem. 2010 Feb 26;285(9):6477-88
pubmed: 20038581
Clin Oncol (R Coll Radiol). 2022 Jan;34(1):e18-e24
pubmed: 34563446
Clin Cancer Res. 2019 Feb 1;25(3):989-999
pubmed: 30206165
Theranostics. 2021 Oct 17;11(20):9884-9903
pubmed: 34815793
Nat Commun. 2013;4:1853
pubmed: 23673638
Nature. 2010 Aug 12;466(7308):869-73
pubmed: 20668451
Eur Respir J. 2020 Feb 20;55(2):
pubmed: 31744834
Clin Cancer Res. 2020 Apr 15;26(8):1846-1855
pubmed: 31757877
Immunity. 2009 Jun 19;30(6):875-87
pubmed: 19501000
Cancer Cell. 2016 Nov 14;30(5):668-681
pubmed: 27846389
J Clin Med. 2021 Nov 22;10(22):
pubmed: 34830742
Cancer Cell. 2016 Aug 8;30(2):243-256
pubmed: 27505671
Curr Protoc Immunol. 2018 Nov;123(1):e58
pubmed: 30238640
Front Immunol. 2021 Aug 31;12:661323
pubmed: 34531850
Nature. 2005 Dec 8;438(7069):820-7
pubmed: 16341007
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Cancer Immunol Res. 2018 Dec;6(12):1459-1471
pubmed: 30209062
Clin Cancer Res. 2017 Aug 1;23(15):4242-4250
pubmed: 28351930
Cancer Immunol Immunother. 2022 Mar;71(3):579-588
pubmed: 34278517
Cell. 2013 Feb 28;152(5):1173-83
pubmed: 23452860
PLoS One. 2011;6(9):e24370
pubmed: 21931695
Nat Med. 2007 Sep;13(9):1050-9
pubmed: 17704786
Front Oncol. 2021 Sep 24;11:756365
pubmed: 34631593
Oncol Rep. 2016 Apr;35(4):2053-64
pubmed: 26782741
Cell. 2016 Dec 1;167(6):1540-1554.e12
pubmed: 27912061
Clin Cancer Res. 2017 Apr 15;23(8):1920-1928
pubmed: 27827313
Front Immunol. 2019 Feb 07;10:172
pubmed: 30792719
Nat Rev Immunol. 2019 Aug;19(8):477-489
pubmed: 31036962
Nat Commun. 2016 Jul 06;7:12150
pubmed: 27381735
J Exp Med. 2021 Oct 4;218(10):
pubmed: 34477811
Nat Rev Clin Oncol. 2019 Oct;16(10):601-620
pubmed: 31160735
Mol Cancer. 2018 Nov 17;17(1):158
pubmed: 30447690
J Immunol. 2016 Aug 1;197(3):859-71
pubmed: 27307558
J Clin Immunol. 2019 Apr;39(3):277-286
pubmed: 31077002
Nat Cell Biol. 2008 Nov;10(11):1349-55
pubmed: 18820689
JAMA Oncol. 2018 Nov 1;4(11):1543-1552
pubmed: 30193240
Am J Physiol. 1998 Oct;275(4):L687-93
pubmed: 9755100
Tumour Biol. 2014 Jan;35(1):545-51
pubmed: 23949880